SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$3.72B
This Quarter Return
+0.24%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.33B
AUM Growth
+$2.19B
(+102%)
Cap. Flow
+$2.23B
Cap. Flow
% of AUM
51.33%
Top 10 Holdings %
Top 10 Hldgs %
9.94%
Holding
1,042
New
377
Increased
333
Reduced
160
Closed
123
Top Buys
| 1 |
Walmart
WMT
|
+$45.3M |
| 2 |
Adobe
ADBE
|
+$44M |
| 3 |
CrowdStrike
CRWD
|
+$43.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$40.4M |
| 5 |
PACCAR
PCAR
|
+$39.2M |
Top Sells
| 1 |
US Bancorp
USB
|
+$30.3M |
| 2 |
Boeing
BA
|
+$30M |
| 3 |
CF Industries
CF
|
+$14.3M |
| 4 |
Exact Sciences
EXAS
|
+$12.9M |
| 5 |
Xcel Energy
XEL
|
+$10.6M |
Sector Composition
| 1 | Industrials | 17.34% |
| 2 | Technology | 13.67% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 11.71% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Molson Coors Class B
TAP
$9.7B
| $681K | 0.02% |
+13,400
| New | +$681K |
|
627
Emergent Biosolutions
EBS
$425M
| $677K | 0.02% |
99,254
-19,393
| -16% | -$132K |
|
628
FirstCash
FCFS
$6.46B
| $676K | 0.02% |
+6,445
| New | +$676K |
|
|
FBMS
629
DELISTED
The First Bancshares, Inc.
FBMS
| $675K | 0.02% |
25,986
+8,145
| +46% | +$212K |
|
630
Alkami Technology
ALKT
$2.62B
| $666K | 0.02% |
+23,386
| New | +$666K |
|
631
Semtech
SMTC
$5.36B
| $663K | 0.02% |
22,189
| – | – |
|
632
Sutro Biopharma
STRO
$77.2M
| $660K | 0.02% |
225,367
+98,908
| +78% | +$290K |
|
633
Ingredion
INGR
$8.08B
| $657K | 0.02% |
5,730
-8,709
| -60% | -$999K |
|
|
SQSP
634
DELISTED
Squarespace, Inc.
SQSP
| $657K | 0.02% |
+15,049
| New | +$657K |
|
635
MBIA
MBI
$374M
| $656K | 0.02% |
119,535
+77,494
| +184% | +$425K |
|
636
Alarm.com
ALRM
$2.76B
| $656K | 0.02% |
10,323
+2,820
| +38% | +$179K |
|
|
VERV
637
DELISTED
Verve Therapeutics
VERV
| $649K | 0.02% |
132,998
+118,628
| +826% | +$579K |
|
638
Sonic Automotive
SAH
$2.77B
| $645K | 0.01% |
+11,838
| New | +$645K |
|
639
QuantumScape
QS
$4.73B
| $644K | 0.01% |
+130,832
| New | +$644K |
|
640
Arbutus Biopharma
ABUS
$886M
| $643K | 0.01% |
208,152
+105,228
| +102% | +$325K |
|
641
DigitalBridge
DBRG
$2.03B
| $641K | 0.01% |
+46,790
| New | +$641K |
|
642
Stitch Fix
SFIX
$745M
| $636K | 0.01% |
153,360
+55,290
| +56% | +$229K |
|
643
Omeros
OMER
$291M
| $633K | 0.01% |
155,957
| – | – |
|
644
HubSpot
HUBS
$25.8B
| $629K | 0.01% |
+1,067
| New | +$629K |
|
645
John B. Sanfilippo & Son
JBSS
$724M
| $628K | 0.01% |
6,465
+644
| +11% | +$62.6K |
|
646
FIVE9
FIVN
$1.95B
| $627K | 0.01% |
14,213
-12,528
| -47% | -$552K |
|
647
Mersana Therapeutics
MRSN
$36.7M
| $620K | 0.01% |
12,348
+2,983
| +32% | +$150K |
|
648
TriMas Corp
TRS
$1.56B
| $611K | 0.01% |
+23,923
| New | +$611K |
|
|
HSAI
649
Hesai Group
HSAI
$3.71B
| $605K | 0.01% |
144,420
+74,888
| +108% | +$314K |
|
650
C4 Therapeutics
CCCC
$188M
| $600K | 0.01% |
129,801
+78,436
| +153% | +$362K |
|